Enterprise Value
-9.581M
Cash
16.84M
Avg Qtr Burn
-7.817M
Short % of Float
2.19%
Insider Ownership
0.02%
Institutional Own.
16.65%
Qtr Updated
03/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
AL102 Details Benign tumor, Genetic disorder, Achromatopsia | Phase 2/3 Update | |
AL101 Details Carcinoma , Salivary gland carcinoma , Salivary gland, Cancer | Phase 2 Update | |
ADXS- 504 Details Cancer, Prostate cancer | Phase 1 Data readout | |
AL101 Details Leukemia, Acute lymphoblastic leukemia | Failed Discontinued | |
AL101 Details Breast cancer, Cancer | Failed Discontinued |